BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1411 related articles for article (PubMed ID: 33258746)

  • 41. Comparison of 18 F-FDG and 68 Ga-FAPI-04 Uptake in Postoperative Re-evaluation of Gastric, Duodenal, and Colorectal Cancers.
    Liu H; Yang X; Liu L; Qu G; Chen Y
    Clin Nucl Med; 2023 Apr; 48(4):304-308. PubMed ID: 36800254
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fibroblast Activation Protein and Glycolysis in Lymphoma Diagnosis: Comparison of
    Chen X; Wang S; Lai Y; Wang G; Wei M; Jin X; Ding J; Zhang Y; Shi Y; Wang F; Zhu H; Yang Z; Wang X
    J Nucl Med; 2023 Sep; 64(9):1399-1405. PubMed ID: 37385675
    [TBL] [Abstract][Full Text] [Related]  

  • 43.
    Sahin E; Kus T; Aytekin A; Uzun E; Elboga U; Yilmaz L; Cayirli YB; Okuyan M; Cimen V; Cimen U
    J Nucl Med; 2024 Apr; 65(4):512-519. PubMed ID: 38485276
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [
    Guo W; Pang Y; Yao L; Zhao L; Fan C; Ke J; Guo P; Hao B; Fu H; Xie C; Lin Q; Wu H; Sun L; Chen H
    Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1604-1617. PubMed ID: 33179149
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Initial Evaluation of [
    Watabe T; Naka S; Tatsumi M; Kamiya T; Kimura T; Shintani Y; Abe K; Miyake T; Shimazu K; Kobayashi S; Kurokawa Y; Eguchi H; Doki Y; Inohara H; Kato H; Mori Y; Cardinale J; Giesel FL
    J Nucl Med; 2023 Aug; 64(8):1225-1231. PubMed ID: 37268427
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Head-to-head intra-individual comparison of biodistribution and tumor uptake of
    Giesel FL; Kratochwil C; Schlittenhardt J; Dendl K; Eiber M; Staudinger F; Kessler L; Fendler WP; Lindner T; Koerber SA; Cardinale J; Sennung D; Roehrich M; Debus J; Sathekge M; Haberkorn U; Calais J; Serfling S; Buck AL
    Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4377-4385. PubMed ID: 34137945
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of the Relative Diagnostic Performance of [
    Wu J; Wang Y; Liao T; Rao Z; Gong W; Ou L; Chen Y; Zhang C
    Front Oncol; 2021; 11():737827. PubMed ID: 34604078
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Head-to-Head Comparison of [
    Wegen S; van Heek L; Linde P; Claus K; Akuamoa-Boateng D; Baues C; Sharma SJ; Schomäcker K; Fischer T; Roth KS; Klußmann JP; Marnitz S; Drzezga A; Kobe C
    Mol Imaging Biol; 2022 Dec; 24(6):986-994. PubMed ID: 35771317
    [TBL] [Abstract][Full Text] [Related]  

  • 49.
    Shangguan C; Yang C; Shi Z; Miao Y; Hai W; Shen Y; Qu Q; Li B; Mi J
    Int J Radiat Oncol Biol Phys; 2024 Jan; 118(1):285-294. PubMed ID: 37634891
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 68 Ga-FAPI-04 PET/CT for the Evaluation of Cholangiocarcinoma : Comparison With 18 F-FDG PET/CT and Abdominal 68 Ga-FAPI-04 PET/MR.
    Zhang Z; Cheng C; Jiang H; Pan G; Yu Y; Jin G; Zuo C
    Clin Nucl Med; 2024 May; 49(5):409-418. PubMed ID: 38465929
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dual-tracer PET/CT protocol with [
    Wegen S; Weindler J; Voltin CA; van Heek L; Schomäcker K; Fischer T; Marnitz S; Kobe C; Drzezga A; Roth KS
    Strahlenther Onkol; 2024 Jan; 200(1):28-38. PubMed ID: 37584717
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical Utility of F-18 Labeled Fibroblast Activation Protein Inhibitor (FAPI) for Primary Staging in Lung Adenocarcinoma: a Prospective Study.
    Li Y; Lin X; Li Y; Lv J; Hou P; Liu S; Chen P; Wang M; Zhou C; Wang X
    Mol Imaging Biol; 2022 Apr; 24(2):309-320. PubMed ID: 34816283
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of FAPI PET imaging in gastric cancer: a systematic review and meta-analysis.
    Ruan D; Zhao L; Cai J; Xu W; Sun L; Li J; Zhang J; Chen X; Chen H
    Theranostics; 2023; 13(13):4694-4710. PubMed ID: 37649615
    [No Abstract]   [Full Text] [Related]  

  • 54. Comparison of
    Güzel Y; Kaplan İ
    Hell J Nucl Med; 2023; 26(1):26-34. PubMed ID: 37031420
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    Qin C; Shao F; Gai Y; Liu Q; Ruan W; Liu F; Hu F; Lan X
    J Nucl Med; 2022 Jan; 63(1):81-88. PubMed ID: 33863819
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    Giesel FL; Kratochwil C; Lindner T; Marschalek MM; Loktev A; Lehnert W; Debus J; Jäger D; Flechsig P; Altmann A; Mier W; Haberkorn U
    J Nucl Med; 2019 Mar; 60(3):386-392. PubMed ID: 30072500
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Improved cancer detection in Waldeyer's tonsillar ring by
    Serfling S; Zhi Y; Schirbel A; Lindner T; Meyer T; Gerhard-Hartmann E; Lapa C; Hagen R; Hackenberg S; Buck AK; Scherzad A
    Eur J Nucl Med Mol Imaging; 2021 Apr; 48(4):1178-1187. PubMed ID: 33057927
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Head-to-head comparison of [
    Kuten J; Levine C; Shamni O; Pelles S; Wolf I; Lahat G; Mishani E; Even-Sapir E
    Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):743-750. PubMed ID: 34302504
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnostic value of [
    Lin X; Li Y; Wang S; Zhang Y; Chen X; Wei M; Zhu H; Wu A; Yang Z; Wang X
    Front Oncol; 2022; 12():1087792. PubMed ID: 36698416
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Added Value of
    Gu B; Xu X; Zhang J; Ou X; Xia Z; Guan Q; Hu S; Yang Z; Song S
    J Nucl Med; 2022 Jun; 63(6):875-881. PubMed ID: 34593594
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 71.